Biological and clinical significance of haptoglobin polymorphism in humans

Clinical Chemistry

Volumn 42, Issue 10, 1996, Pages 1589-1600

  Langlois, Michel R ^a   Delanghe, Joris R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

acute phase proteins; anhaptoglobinemia; ceruloplasmin; forensic medicine; free radicals; genetic variants; hemoglobin; hemopexin; immune response; interleukin 6; iron; prostaglandin; reference ranges

Indexed keywords

HAPTOGLOBIN;

ATHEROSCLEROSIS; AUTOIMMUNITY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION; INFLAMMATORY DISEASE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; REVIEW;

EID: 0029854812     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.10.1589     Document Type: Review

References (160)

1. Bowman BH. Haptoglobin. In: Bowman BH, ed. Hepatic plasma proteins. San Diego: Academic Press, 1993:159-67.
2. Schultze HE, Heremans JF, eds. Molecular biology of human proteins, Vol. 1: nature and metabolism of extracellular proteins. Amsterdam: Elsevier, 1966:384-402.
3. Giblett ER. The haptoglobin system. Ser Haematol 1968;1:3-20.
4. Lange V. Der Haptoglobin Polymorphismus - nicht nur eine genetische Markierungshilfe [Review]. Anthropol Anz 1992;50: 281-302.
5. Nyman M. Serum haptoglobin. Methodological and clinical studies. Scand J Clin Lab Invest 1959;11(Suppl 39):1-169.
6. Jayle M-F, Judas O. Formule glycoprotéidique du plasma sanguin. Helv Chim Acta 1946;29:1310.
7. Smithies O. Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. Biochem J 1955;61:629-41.
8. Thomas L, Fateh-Moghadam A, Guder WG, Hofmann W, Reiber H, Lammers M, eds. Proteindiagnostik. Frankfurt a.M., Germany: Behringwerke, 1991:92-3.
9. Smithies O, Connell GE, Dixon GH. Inheritance of haptoglobin subtypes. Am J Hum Genet 1962;14:14-21.
10. Black JA, Dixon GH. Amino-acid sequence of alpha-chains of human haptoglobins. Nature 1968;218:736-41.
11. Bowman BH, Kurosky A. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 1982;12:189-261.
12. Galatius-Jensen F. The haptoglobins. A genetical study [Thesis]. Copenhagen: Univ Inst of Forensic Med, 1960:117pp.
13. Maeda N, Yang F, Barnett DR, Bowman BH, Smithies O. Duplication within the haptoglobin Hp2 gene. Nature 1984;309: 131-5.
14. Kurosky A, Barnett DR, Lee T-H, Touchstone B, Hay RE, Arnott MS, et al. Covalent structure of human haptoglobin: a serine protease homolog. Proc Natl Acad Sci U S A 1980;77:3388-92.
15. Nilsson M, Bøg-Hansen T. An approach to fractionation of human serum proteins with some lectins. Protides Biol Fluids 1979;27: 599-602.
16. Katnik I. Studies on haptoglobin binding to concanavalin A, Biochim Biophys Acta 1984;790:8-14.
17. Turner GA. N-Glycosylation of serum proteins in disease and its investigation using lectins [Review]. Clin Chim Acta 1992;208: 149-71.
18. Allison AC, Blumberg BS, Rees W. Haptoglobin types in British, Spanish Basque and Nigerian African population [Letter]. Nature 1958;181:824.
19. Giblett ER. Haptoglobin types in American Negroes [Letter]. Nature 1959;183:192.
20. Raynes JG, Eagling S, McAdam KP. Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6. Clin Exp Immunol 1991;83:488-91.
21. Oliviero S, Cortese R. The human haptoglobin gene promoter: interleukin-6-response elements interact with a DNA-binding protein induced by interleukin-6. EMBO J 1989;8:1145-51.
22. Moretti J, Borel J, Dobryszycka W, Jayle M. Determination de la demi-vie de l'haptoglobine plasmatique humaine. Biochim Biophys Acta 1963;69:205-11.
23. Louagie H, Delanghe J, De Sombere I, De Buyzere M, Hauser P, Leroux-Roels G. Haptoglobin polymorphism and immune response after hepatitis B vaccination. Vaccine 1993;11:1188-90.
24. Van Sande M, Van Ros G, Druet R. Determination of haptoglobin-groups frequencies by starch-gel and agar-gel electrophoresis: application to Belgian and Barundi populations. Nature 1963; 197:603-4.
25. Thomas L. Haptoglobin/Hämopexin. In: Thomas L, ed. Labor und Diagnose, 4th ed. Marburg: Medizinische Verlags., 1992:813-20.
26. Hever O. Relations entre les phénotypes d'haptoglobine dans diverses maladies. Presse Méd 1969;30:1081-2.
27. Fröhlander N, Johnson O. Haptoglobin groups in acute myocardial infarction. Hum Hered 1989;39:345-50.
28. Bowman JE. Haptoglobin and transferrin differences in some Iranian populations. Nature 1964;201:88.
29. Padma T, Valli VV. ABO blood groups, intestinal alkaline phosphatase and haptoglobin types in patients with serum hepatitis. Hum Hered 1988;38:367-71.
30. Mitchell RJ, Carzino R, Janardhana V. Associations between the two serum proteins haptoglobin and transferrin and leukemia. Hum Hered 1988;38:144-50.
31. Blackwell RQ, Thephusdin C. Distribution of haptoglobin among Thais. Nature 1963;197:503.
32. Zhao H, Zhang G, Duan Y, Yu S. Haptoglobin types in Chinese ethnic groups. Hum Hered 1993;43:131-3.
33. Blackwell RQ, Lin T-Y, Shiao D. Distribution of haptoglobins among Chinese in Taiwan. Nature 1962;193:284-5.
34. Shindo S. Haptoglobin subtyping with anti-haptoglobin α chain antibodies. Electrophoresis 1990;11:483-8.
35. Sutton HE, Matson GA, Robinson AR, Kouchy RW. Distribution of haptoglobin, transferrin, and hemoglobin types among Indians of Southern Mexico and Guatemala. Am J Hum Genet 1960;12: 338.
36. Nagel R, Etcheverry R. Types of haptoglobins in Araucanian Indians of Chile. Nature 1963;197:187-8.
37. Nagel R, Etcheverry R, Guzman C. Haptoglobin types in inhabitants of Easter Island. Nature 1964;201:216-7.
38. Flory LL. Serum factors of Australian aborigines from North Queensland. Nature 1964;201:508-9.
39. Arcoleo JP, Greer J. Hemoglobin binding site and its relationship to the serine protease-like active site of haptoglobin. J Biol Chem 1982;257:10063-8.
40. Dobryszycka W, Przysiecki B. Structural similarities among concanavalin A, haptoglobin, and trypsin. FEBS Lett 1984;171: 85-8.
41. Bowman BH, Yang F. DNA sequencing and chromosomal locations of human plasma protein genes. In: Putnam FW, ed. The plasma proteins. Structure, function and genetic control, 2nd ed. London: Academic Press, 1987:12-48.
42. McCormick DJ, Atassi MZ. Hemoglobin binding with haptoglobin: delineation of the haptoglobin binding site on the alpha-chain of human hemoglobin. J Protein Chem 1990;9:735-42.
43. Sakata S, Yoshioka N, Atassi M. Human haptoglobin binds to myoglobin. Biochim Biophys Acta 1986;873:312-5.
44. Kino J, Tsunoo H, Higa Y, Takami M. Hemoglobin-haptoglobin receptor in rat liver plasma membrane. J Biol Chem 1980;255: 9616-20.
45. Kino K, Mizumoto K, Watanabe J, Tsunoo H. Immunohistochemical studies on hemoglobin-haptoglobin and hemoglobin catabolism sites. J Histochem Cytochem 1987;35:381-6.
46. Javid J. The effect of haptoglobin-polymer size on hemoglobin binding capacity. Vox Sang 1965;10:320-5.
47. Agil A, Fuller CJ, Jialal I. Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction. Clin Chem 1995;41:220-5.
48. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819-28.
49. Sadrzadeh SMH, Graf E, Panter SS, Hallaway PE, Eaton JW. Hemoglobin - a biologic Fenton reagent. J Biol Chem 1984;259: 14354-6.
50. Fenton HJH. Oxidation of certain organic acids in the presence of ferrous salts. Proc Chem Soc 1899;15:224.
51. Haber F, Weiss J. The catalytic decomposition of hydrogen peroxide by iron salts. Proc R Soc A 1934;147:332.
52. Moison RM, Palinckx JJ, Roest M, Houdkamp E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993;341:79-82.
53. BaIIa J, Jacob HS, Balla G, Nath K, Eaton JW, Vercelotti GM. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A 1993;90:9285-9.
54. Gutteridge JMC. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219-23.
55. Smith AB, Esko JD, Hajduk SL. Killing of trypanosomes by the human haptoglobin-related protein. Science 1995;268:284-6.
56. Smith AB, Hajduk SL. Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum. Proc Natl Acad Sci U S A 1995;92:10262-2.
57. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
58. Green SJ. Nitric oxide in mucosal immunity. Nature Med 1995; 1:515-7.
59. Weiss G, Wachter H, Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol Today 1995;16:495-500.
60. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH. The nature of endothelium-derived vascular relaxant factor. Nature 1984;308:645-7.
61. Martin W, Villani GM, Jothianandan JV, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708-16.
62. Collins P, Burman J, Chung H, Fox K. Hemoglobin inhibits endothelium-dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation 1993;87:80-5.
63. Edwards DH, Griffith TM, Ryley HC, Henderson AH. Haptoglobin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoid. Cardiovasc Res 1986;20: 549-56.
64. Jue D-M, Shim B-S, Kang Y-S. Inhibition of prostaglandin synthase activity of sheep seminal vesicular gland by human serum haptoglobin. Mol Cell Biochem 1983;51:141-7.
65. Kendall PA, Saeed SA, Collier HOJ. Identification of endogenous inhibitor of prostaglandin synthetase with haptoglobin and albumin. Biochem Soc Trans 1979;7:543-5.
66. Lucas A, Collier HOJ, Saeed SA, Mitchell MD. Haptoglobin, prostaglandins, and ductus arteriosus in preterm infants [Letter]. Lancet 1980;i:1186-7.
67. Barclay R. The role of iron in infection. Med Lab Sci 1985;42: 166-77.
68. Eaton JW, Brandt P, Mahoney JR, Lee JT. Haptoglobin: a natural bacteriostat. Science 1982;215:691-3.
69. Lewis LA, Dyer DW. Identification of an iron-regulated outer membrane protein of Neisseria meningitidis involved in the utilization of hemoglobin complexed to haptoglobin. J Bacteriol 1995;177:1299-306.
70. Pickett CL, Auffenberg T, Pesci EC, Sheen VL, Jusuf SS. Iron acquisition and hemolysin production by Campylobacter jejuni. Infect Immun 1992;60:3872-7.
71. Otto BR, Sparrius M, Wors DJ, de Graaf FK, MacLaren DM. Utilization of haem from the haptoglobin-haemoglobin complex by Bacteroides fragilis. Microb Pathog 1994;17:137-47.
72. Zakaria-Meehan Z, Massad G, Gimpson LM, Travis JC, Oliver JD. Ability of Vibrio vulnificus to obtain iron from hemoglobin-haptoglobin complexes. Infect Immun 1988;56:275-7.
73. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91: 977-85.
74. Cockerill GW, Gamble JR, Vadas MA. Angiogenesis: models and modulators. Int Rev Cytol 1995;159:113-60.
75. Kliffen M, de Jong PT, Luider TM. Protein analysis of human maculae in relation to age-related maculopathy. Lab Invest 1995;73:267-72.
76. Köhler W, Prokop O. Relationship between haptoglobin and Streptococcus pyogenes T4 antigens [Letter]. Nature 1978;271: 373.
77. Prokop O, Köhler W. Haptoglobins act similar to antibodies. Zentralbl Gynäkol 1979;101:1111-6.
78. Baskies AM, Chretien PB, Weiss JF, Makuch RW, Beveridge RA, Catalona WJ, Spiegel HE. Serum glycoproteins in cancer patients, first reports of correlations with in vitro and in vivo parameters of cellular immunity. Cancer 1980;45:3050-60.
79. Kudo J, Okubo H, Ikuta T, Hirata Y, Ishibashi H. Interaction of acute phase reactive (APR) proteins with lectins: its relationship to lymphocyte transformation. Biomed Res 1982;3:417-21.
80. Basler MW, Burrel R. Purification of haptoglobin and its effects on lymphocytes and alveolar lymphocyte responses. Inflammation 1983;7:387-400.
81. Hanasaki K, Powell LD, Varki A. Binding of human plasma sialoglycoproteins by the B cell specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. J Biol Chem 1995;270:7543-50.
82. Barclay AN, Birkeland ML, Brown MH, Beyers AD, Davis SJ, Somoza C, Williams AF, eds. The leucocyte antigen facts book. London: Academic Press, 1993:424pp.
83. Kehrl JH. CD22 Workshop Panel report. In: Leucocyte Typing V. Proceedings of the fifth international workshop on human leucocyte differentiation antigens. Oxford, UK: University Press, 1995: 523-5.
84. Powell LD, Sgroi D, Sjoberg ER, Stamenkovic I, Varki A. Natural ligands of the B cell adhesion molecule CD22β carry N-linked oligosaccharides with α-2,6-linked sialic acids that are required for recognition. J Biol Chem 1993;268:7019-27.
85. Stamenkovic I, Seed B. The B cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 1990;345:74-7.
86. Engel P, Nojima Y, Rothstein D, Zhou L-J, Wilson GL, Kehrl JH, Tedder TF. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils and monocytes. J Immunol 1993;150:4719-32.
87. Law C-L, Sidorenko SP, Clark EA. Regulation of lymphocyte activation by the cell-surface molecule CD22. Immunol Today 1994;15:442-9.
88. Oh SK, Pavlotski N, Tauber AI. Specific binding of haptoglobin to human neutrophils and its functional consequences. J Leukoc Biol 1990;47:142-8.
89. Wagner L, Gessl A, Baumgartner Parzer S, Base W, Waldhausl W, Pasternack MS. Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J Immunol 1996;156:1989-96.
90. El Ghmati SM, Van Hoeyveld EM, Van Strijp JAG, Ceuppens JL, Stevens EAM. Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol 1996;156:2542-52.
91. Snellman O, Sylvén B. Haptoglobin acting as a natural inhibitor of cathepsin B activity [Letter]. Nature 1967;216:1033.
92. Offner GD, Gong D, Afdhal NH. Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N. Gastroenterology 1994;106:755-62.
93. Yamashita G, Corradini SG, Secknus R, Takabayashi A, Williams C, Hays L, et al. Biliary haptoglobin, a potent promotor of cholesterol crystallization at physiological concentrations. J Lipid Res 1995;36:1325-33.
94. Standing S, Price CP. A kinetic method for the determination of haptoglobin as haemoglobin binding capacity. Clin Chim Acta 1976;66:393-403.
95. Kickler S, Fong PF, Johnson GF, Solomon HM. Kinetic determination of serum haptoglobin with a centrifugal analyzer. Clin Chem 1976;22:1962-7.
96. Shim BS, Jue DM. Simple determination of haptoglobin level in serum. Clin Chim Acta 1984;136:145-53.
97. Braun HJ, Aly FW. Problems in the quantitative estimation of human serum haptoglobin by single radial immunodiffusion. Clin Chim Acta 1969;26:588-90.
98. Van Rijn HJM, Kruit WJH, Schrijver J. Haptoglobin typing; is it clinically necessary for a reliable determination of haptoglobin with the single radial immunodiffusion technique? J Clin Chem Clin Biochem 1984;22:109-12.
99. Ramakers JM, Kreutzer HJH. Turbidimetric determination of haptoglobin. J Clin Chem Clin Biochem 1976;14:407-10.
100. Van Rijn H, Van Der Wilt W, Stroes J, Schrijver J. Is the turbimetric immunoassay of haptoglobin phenotype-dependent? Clin Biochem 1987;20:245-8.
101. Van Lente F, Marchand A, Galen RS. Evaluation of a nephelometric assay for haptoglobin and its clinical usefulness. Clin Chem 1979;25:2007-10.
102. Fink PC, Roemer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM, Dubs RW. Measurement of proteins with the Behring Nephelometer: a multicentre evaluation. J Clin Chem Clin Biochem 1989;27:261-76.
103. Katnik I, Lammler C, Guszczynski T, Dobryszycka W. Quantitation of human haptoglobin by ELISA system based on streptococcal haptoglobin receptors. Arch Immunol Ther Exp (Warsz) 1993;42: 105-9.
104. Alonso A, Visedo G, Sancho M, Fernandez-Piqueras J. Haptoglobin subtyping by isoelectric focusing in miniaturized polyacrylamide gels rehydrated in presence of 2-mercaptoethanol. Electrophoresis 1990;11:321-4.
105. John A, Henke J, Morich FJ. Identification of a so-far not characterized human serum protein associated with essential hypertension. Electrophoresis 1985;6:292-5.
106. Bias WB, Zachary AA. Basic principles of paternity determination. In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology, 3th ed. Washington, DC: Am Soc for Microbiol, 1986:902-11.
107. Whicher JT, Ritchie RF, Johnson AM, Baudner S, Bienvenu J, Blirup-Jensen S, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40: 934-8.
108. Tietz NW, Shuey DF, Wekstein DR. Laboratory values in fit aging individuals - sexagenarians through centenarians. Clin Chem 1992;38:1167-85.
109. Kanakoudi F, Drossou V, Tzimouli V, Diamanti E, Konstantinidis T, Germenis A, Kremenopoulos G. Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 1995;41:605-8.
110. Silverman LM, Christenson RH. Amino acids and proteins. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 2nd ed. Philadelphia: WB Saunders, 1994:625-734.
111. Maes M, Cooreman W, Delanghe J, Scharpé S, Wauters A, Neels H, et al. Components of biological variation in plasma haptoglobin: relationships to plasma fibrinogen and immune variables, including interleukin-6 and its receptor. Clin Chim Acta 1995; 239:23-35.
112. Fröhlander N. Haptoglobin groups and serum cholesterol levels. Hum Hered 1987;37:323-5.
113. Børresen AL, Leren T, Berg K, Solaas MH. Effect of haptoglobin subtypes on serum lipid levels. Hum Hered 1987;37:150-6.
114. Delanghe J, Duprez D, De Buyzere M, Bergez B, Callens B, Leroux-Roels G, Clement D. Haptoglobin phenotypes and complications in established essential arterial hypertension. J Hypertens 1993;11:861-7.
115. Norum K, Gjone E, Glomset J. Familial lecithin:cholesterol acyltransferase deficiency, including fish eye disease. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The metabolic bases of inherited disease, 6th ed. New York: McGraw-Hill, 1989:1181-94.
116. Goldstein IM, Kaplan HB, Edelson HS, Weissmann G. Ceruloplasmin - a scavenger of Superoxide anion radicals. J Biol Chem 1979;254:4040-5.
117. Thompson S, Turner GA. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer 1987;56:605-10.
118. Thompson S, Stappenbeck R, Turner GA. A multiwell lectin-binding assay using Lotus tetragonolobus for measuring different glycosylated forms of haptoglobin. Clin Chim Acta 1989;180: 277-84.
119. Thompson S, Kelly CA, Griffiths ID, Turner GA. Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease. Clin Chim Acta 1989;184:251-8.
120. Mann AC, Record CO, Self CH, Turner GA. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clin Chim Acta 1994;227:69-78.
121. Tietz NW, ed. Clinical guide to laboratory tests, 3rd ed. Philadelphia: WB Saunders, 1995:306-9.
122. 1-antitrypsin, haptoglobin, ceruloplasmin, lower retinol-binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 1992;24:183-192.
123. Maes M, Scharpé S, Meltzer HY, Cosyns P. Relationship between haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry 1993;34:690-701.
124. Kaminskaia GO, Zhukova NL, Naumov VH. Interrelations between genetically determined haptoglobin types and the course of the postoperative period in chronic forms of pulmonary tuberculosis. Probl Tuberk 1989;8:3-7.
125. Fedoseeva SV, Iusopova MM, Chukanova VP, Pospelov LE. Course of infiltrating pulmonary tuberculosis depending on the patient's genotype. Probl Tuberk 1993;12:8-10.
126. Nevo S, Sutton H. Association between response to typhoid vaccination and known genetic markers. Am J Hum Genet 1979;20:461-9.
127. Friedel E, Schmidt M, Apstoloff E, Geserick G, Montag T, Kuhlmay J, Bode F. Ein wahrscheinlicher Zusammenhang zwischen Haptoglobintyp und immunogener Reactivität nach Tetanusimmunierung. Dtsch Gesundheitsw 1979;34:376-7.
128. Montag T, Geserick G, Furl S, Montag D, Adamczyck B, Forster A. Der Zusammenhang zwischen dem genetischen Haptoglobintyp und der humoralen Immunantwort nach Grippeschutzimpfung. Dtsch Gesundheitsw 1980;35:1227-30.
129. Louagie HK, Brouwer JT, Delanghe JR, De Buyzere ML, Leroux-Roels GG. Haptoglobin polymorphism and chronic hepatitis C. J Hepatol 1996;25:10-4.
130. Delanghe J, Van Acker J, Hemmer R, Van der Groen G, Van Wanzeele F, Verhofstede K. Haptoglobin polymorphism and progression of human immune deficiency virus infection [Abstract]. Proceedings of the XVI International Congress of Clinical Chemistry. London: Association of Clinical Biochemists, 1996: 77.
131. Beckman G, Beckman L, Cedergren B, Göransson K, Liden S. Blood groups, serum groups and red cell enzyme types in allergic contact dermatitis. Hum Hered 1981;31:54-60.
132. Fröhlander N, Stjernberg N. Association between haptoglobin groups and hereditary predisposition for bronchial asthma. Hum Hered 1989;39:7-11.
133. Rantapää Dahlqvist S, Fröhlander N. Haptoglobin groups and rheumatoid arthritis. Hum Hered 1985;35:207-11.
134. Rantapää Dahlqvist S, Beckman G, Beckman L. Serum protein markers in systemic lupus erythematosus. Hum Hered 1988;38: 44-7.
135. Tsamantanis C, Delinassios JG, Kottaridis S, Christodoulou C. Haptoglobin types in breast carcinoma. Hum Hered 1980;30: 44-5.
136. Bartel U, Elling D, Geserick G. Distribution of haptoglobin phenotypes in gynecologic tumors. Zentralbl Gynäkol 1985;107: 1492-5.
137. Beckman G, Eklund A, Fröhlander N, Stjernberg N. Haptoglobin groups and lung cancer. Hum Hered 1986;36:258-60.
138. Benkmann H-G, Hanssen H-P, Ovenbeck R, Goedde HW. Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients. Hum Hered 1987;37:290-3.
139. Fröhlander N, Stendahl U. Haptoglobin groups in ovarian carcinoma. Hum Hered 1988;38:180-2.
140. Mourant AE, Kopec A, Domaniewska-Sobczak K, eds. Blood groups and diseases. Oxford, UK: University Press, 1978:23-8.
141. Ananthakrishnan R, Beck W, Walter H, ArndtHauser A, Gumbel W, Leithoff H, et al. A mother-child combination analysis for ABO-Hp interaction. Humangenetik 1973;18:203-6.
142. Padma T, Murthy JS. Association of genetic markers with some eye diseases. Acta Anthropogenet 1983;7:1-12.
143. Ostrowski RS, Travis JC, Talley ES. The association of Hp1 and sickle cell disease. Hum Hered 1987;37:193-5.
144. Germenis A, Babionitakis A, Kaloterakis A, Filiotou A, Fertakis A. Group-specific component and haptoglobin phenotypes in multiple myeloma. Hum Hered 1983;33:188-91.
145. Weinberger M, Miller J, Fineberg N, Luft F, Grim C, Christian J. Association of haptoglobin with sodium sensitivity and resistance of blood pressure. Hypertension 1987;10:443-6.
146. Kojima S, Inenaga T, Matsuoka H, Kuramochi M, Omae T, Nara Y, Yamori Y. The association between salt-sensitivity of blood pressure and some polymorphic factors. J Hypertens 1994;12: 797-801.
147. Delanghe J, Duprez D, De Buyzere M, Bergez B, Claeys L, Leroux-Roels G, Clement D. Refractory hypertension is associated with the haptoglobin 2-2 phenotype. J Cardiovasc Risk 1995;2:131-6.
148. Chandra T, Padma T, Vishnupriya S, Venkat Raman R. Haptoglobin polymorphism in pregnancy induced hypertension [Abstract]. Am J Hum Genet 1991;49:130.
149. Chapelle J-P, Albert A, Smeets J-P, Heusghem C, Kulbertus HE. Effect of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med 1982;307:457-63.
150. Delanghe J, Cambier B, De Buyzere M, Claeys L, Van Cauwelaert P. Haptoglobin polymorphism, a genetic risk factor in coronary bypass surgery [Abstract]. Acta Cardiol 1994;49:66.
151. Maes M, Delanghe J, Scharpé S, Meltzer HY, Cosyns P, Suy E, Bosmans E. Haptoglobin phenotypes and gene frequencies in unipolar major depression. Am J Psychiatry 1994;151:112-6.
152. Williamson WA, Greenwood BM. Impairment of the immune response to vaccination after acute malaria. Lancet 1978;i: 1328-9.
153. Stastny JJ, Fossilen E. Quantitative alteration of some aortic intima proteins in fatty streaks and fibro-fatty lesions. Exp Mol Pathol 1992;57:205-14.
154. Jang IK, Lassila R, Fuster V. Atherogenesis and inflammation. Eur Heart J 1993:14(Suppl K):2-6.
155. Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 1993;69(Suppl):38-41.
156. Jacob HS. Newly recognized causes of atherosclerosis: the role of microorganisms and of vascular iron overload. J Lab Clin Med 1994;123:808-16.
157. Horrobin DF. The role of prostaglandins and prolactin in depression, mania and schizophrenia. Postgrad Med J 1977;53(Suppl 4):160-5.
158. Linoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN. CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 1983;40:405-6.
159. Panter SS, Sadrzadeh SMH, Hallaway PE, Haines JL, Anderson VE, Eaton JW. Hypohaptoglobinemia associated with familial epilepsy. J Exp Med 1985;161:748-54.
160. Turowska B, Gurda M, Wozniak Z. ABO, MN, Kell, Hp and Gm1 markers in elderly humans. Mater Med Pol 1991;23:7-12.